A Repeat Dose Positron Emission Tomography Study With GSK1144814

NCT01209039 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

41

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: GSK1144814
DRUG: GSK1144814
DRUG: GSK1144814

Sponsor

GlaxoSmithKline